 Impact of stronger intellectual property rights regime on innovation: Evidence from de alio versus de novo Indian bio-pharmaceutical firmsThakur–Wernz, Pooja and Christian Wernz Journal of Business Research, 2022, vol. 138, issue C, 457-473 Abstract: We examine the impact of a stronger intellectual property rights (IPR) regime through the adoption of Trade-Related Aspects of Intellectual Property Rights (TRIPS) on innovation by Indian firms in the bio-pharmaceutical industry. We find that differences in the IPR regime at the time a firm was founded led to subsequent differences in firms’ propensity to innovate and their nature of innovations. Building on institutional change theory, we argue that firms created under the pre-TRIPS regime, which we refer to as de alio firms, have a lower propensity to innovate and have a focus on process innovations. De novo firms, which are firms created under TRIPS, have a greater propensity to innovate and have a focus on product innovations. Further, we study how international technology alliances have helped Indian bio-pharmaceutical firms to overcome their limitations arising due to institutional imprints and to improve their innovation capabilities. Data on 164 Indian bio-pharmaceutical firms from 1995 to 2018 is used to empirically test our hypotheses. Keywords: India; TRIPS; Innovation; Institutional change; De novo firms; De alio firms (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:eee:jbrese:v:138:y:2022:i:c:p:457-473 DOI: 10.1016/j.jbusres.2021.08.074 Access Statistics for this article Journal of Business Research is currently edited by A. G. Woodside More articles in Journal of Business Research from Elsevier |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.